---
document_datetime: 2025-11-23 08:01:01
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/levviax.html
document_name: levviax.html
version: success
processing_time: 0.0996229
conversion_datetime: 2025-12-26 19:21:20.962967
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Levviax

[RSS](/en/individual-human-medicine.xml/65578)

##### Withdrawn

This medicine's authorisation has been withdrawn

telithromycin

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 9 July 2001 the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Levviax 400 mg film coated tablets.

The marketing authorisation holder (MAH) responsible for Levviax is Aventis Pharma S.A. On 13 November 2007, the European Commission was notified by the MAH of its decision to voluntarily withdraw the marketing authorisation for Levviax for commercial reasons. Levviax was never marketed in the European Union. Ketek is an identical product available in the European Union. On 18 December 2007 the European Commission issued a decision to withdraw the marketing authorisation for Levviax.

Pursuant to this decision the European Public Assessment Report for Levviax is updated to reflect that the marketing authorisation is no longer valid.

Levviax : EPAR - Summary for the public

English (EN) (351.7 KB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/overview/levviax-epar-summary-public_en.pdf)

[Other languages (18)](#file-language-dropdown-409)

español (ES) (354.3 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/es/documents/overview/levviax-epar-summary-public_es.pdf)

čeština (CS) (413.45 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/cs/documents/overview/levviax-epar-summary-public_cs.pdf)

dansk (DA) (351.73 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/da/documents/overview/levviax-epar-summary-public_da.pdf)

Deutsch (DE) (566.66 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/de/documents/overview/levviax-epar-summary-public_de.pdf)

eesti keel (ET) (348.02 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/et/documents/overview/levviax-epar-summary-public_et.pdf)

ελληνικά (EL) (685.01 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/el/documents/overview/levviax-epar-summary-public_el.pdf)

français (FR) (352.16 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/fr/documents/overview/levviax-epar-summary-public_fr.pdf)

italiano (IT) (350.94 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/it/documents/overview/levviax-epar-summary-public_it.pdf)

latviešu valoda (LV) (420.08 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/lv/documents/overview/levviax-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (389.27 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/lt/documents/overview/levviax-epar-summary-public_lt.pdf)

magyar (HU) (409.43 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/hu/documents/overview/levviax-epar-summary-public_hu.pdf)

Nederlands (NL) (355.92 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/nl/documents/overview/levviax-epar-summary-public_nl.pdf)

polski (PL) (415.23 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/pl/documents/overview/levviax-epar-summary-public_pl.pdf)

português (PT) (346.62 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/pt/documents/overview/levviax-epar-summary-public_pt.pdf)

slovenčina (SK) (401.31 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sk/documents/overview/levviax-epar-summary-public_sk.pdf)

slovenščina (SL) (397.25 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sl/documents/overview/levviax-epar-summary-public_sl.pdf)

Suomi (FI) (345.84 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/fi/documents/overview/levviax-epar-summary-public_fi.pdf)

svenska (SV) (353.17 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sv/documents/overview/levviax-epar-summary-public_sv.pdf)

## Product information

Levviax : EPAR - Product Information

English (EN) (450.33 KB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/product-information/levviax-epar-product-information_en.pdf)

[Other languages (21)](#file-language-dropdown-499)

български (BG) (671.09 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/bg/documents/product-information/levviax-epar-product-information_bg.pdf)

español (ES) (471.76 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/es/documents/product-information/levviax-epar-product-information_es.pdf)

čeština (CS) (572.21 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/cs/documents/product-information/levviax-epar-product-information_cs.pdf)

dansk (DA) (467.43 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/da/documents/product-information/levviax-epar-product-information_da.pdf)

Deutsch (DE) (478.45 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/de/documents/product-information/levviax-epar-product-information_de.pdf)

eesti keel (ET) (463.19 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/et/documents/product-information/levviax-epar-product-information_et.pdf)

ελληνικά (EL) (733.85 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/el/documents/product-information/levviax-epar-product-information_el.pdf)

français (FR) (481.05 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/fr/documents/product-information/levviax-epar-product-information_fr.pdf)

italiano (IT) (473.03 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/it/documents/product-information/levviax-epar-product-information_it.pdf)

latviešu valoda (LV) (614.5 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/lv/documents/product-information/levviax-epar-product-information_lv.pdf)

lietuvių kalba (LT) (559.88 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/lt/documents/product-information/levviax-epar-product-information_lt.pdf)

magyar (HU) (547.77 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/hu/documents/product-information/levviax-epar-product-information_hu.pdf)

Malti (MT) (575.09 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/mt/documents/product-information/levviax-epar-product-information_mt.pdf)

Nederlands (NL) (475.83 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/nl/documents/product-information/levviax-epar-product-information_nl.pdf)

polski (PL) (591.02 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/pl/documents/product-information/levviax-epar-product-information_pl.pdf)

português (PT) (476.84 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/pt/documents/product-information/levviax-epar-product-information_pt.pdf)

română (RO) (558.97 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/ro/documents/product-information/levviax-epar-product-information_ro.pdf)

slovenčina (SK) (555.82 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sk/documents/product-information/levviax-epar-product-information_sk.pdf)

slovenščina (SL) (505.04 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sl/documents/product-information/levviax-epar-product-information_sl.pdf)

Suomi (FI) (464.06 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/fi/documents/product-information/levviax-epar-product-information_fi.pdf)

svenska (SV) (463.29 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sv/documents/product-information/levviax-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** A22/41 31/05/2007

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Levviax : EPAR - All Authorised presentations

English (EN) (272.97 KB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_en.pdf)

[Other languages (20)](#file-language-dropdown-248)

български (BG) (556.7 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/bg/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_bg.pdf)

español (ES) (483.38 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/es/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_es.pdf)

čeština (CS) (539.8 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/cs/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (495.13 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/da/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (488.81 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/de/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (275.35 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/et/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (563.13 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/el/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_el.pdf)

français (FR) (484.61 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/fr/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (271.27 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/it/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (319.77 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/lv/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (295.4 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/lt/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (309.43 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/hu/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_hu.pdf)

Nederlands (NL) (485.33 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/nl/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_nl.pdf)

polski (PL) (543.07 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/pl/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_pl.pdf)

português (PT) (272.27 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/pt/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_pt.pdf)

română (RO) (284.35 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/ro/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (318.38 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sk/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (295.23 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sl/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (489.94 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/fi/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (274.56 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sv/documents/all-authorised-presentations/levviax-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Levviax Active substance telithromycin International non-proprietary name (INN) or common name telithromycin Therapeutic area (MeSH)

- Community-Acquired Infections
- Pharyngitis
- Bronchitis, Chronic
- Pneumonia
- Tonsillitis
- Sinusitis

Anatomical therapeutic chemical (ATC) code J01FA15

### Pharmacotherapeutic group

Antibacterials for systemic use

### Therapeutic indication

When prescribing Levviax consideration should be given to official guidance on the appropriate use of antibacterial agents and the local prevalence of resistance (see also sections 4.4 and 5.1).

## Authorisation details

EMA product number EMEA/H/C/000355 Marketing authorisation holder

Aventis Pharma S.A.

20 avenue Raymond Aron 92165 Antony Cedex France

Marketing authorisation issued 09/07/2001 Withdrawal of marketing authorisation 09/07/2001 Revision 10

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Levviax : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (301.72 KB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/procedural-steps-after/levviax-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Levviax : EPAR - Procedural steps taken before authorisation

English (EN) (515.05 KB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/procedural-steps/levviax-epar-procedural-steps-taken-authorisation_en.pdf)

Levviax : EPAR - Scientific Discussion

English (EN) (529.61 KB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/scientific-discussion/levviax-epar-scientific-discussion_en.pdf)

**This page was last updated on** 14/02/2008

## Share this page

[Back to top](#main-content)